UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (217) 217
life sciences & biomedicine (205) 205
humans (176) 176
oncology (170) 170
female (161) 161
breast cancer (128) 128
middle aged (116) 116
aged (102) 102
adult (100) 100
cancer (97) 97
breast neoplasms - drug therapy (89) 89
breast neoplasms - pathology (69) 69
life sciences (62) 62
antineoplastic combined chemotherapy protocols - therapeutic use (58) 58
treatment outcome (45) 45
[sdv.can]life sciences [q-bio]/cancer (43) 43
care and treatment (42) 42
metastasis (42) 42
breast neoplasms - metabolism (40) 40
chemotherapy (40) 40
prognosis (40) 40
trastuzumab (39) 39
tumors (38) 38
aged, 80 and over (36) 36
male (35) 35
clinical trials (33) 33
disease-free survival (33) 33
antineoplastic combined chemotherapy protocols - adverse effects (32) 32
breast neoplasms - genetics (30) 30
neoplasm staging (30) 30
antineoplastic agents - therapeutic use (29) 29
medicine & public health (29) 29
receptor, erbb-2 - metabolism (29) 29
erbb-2 protein (28) 28
research (28) 28
analysis (26) 26
breast neoplasms - mortality (26) 26
epidermal growth factor (25) 25
hematology, oncology and palliative medicine (24) 24
animals (22) 22
cancer therapies (22) 22
metastases (22) 22
neoplasm metastasis (22) 22
pharmacology & pharmacy (22) 22
genetic aspects (21) 21
health aspects (21) 21
patients (21) 21
gene expression (20) 20
metastatic breast cancer (20) 20
survival (20) 20
young adult (20) 20
antineoplastic agents (18) 18
kaplan-meier estimate (18) 18
drug therapy (17) 17
research article (17) 17
investigating or analysing materials by determining theirchemical or physical properties (16) 16
measuring (16) 16
mutation (16) 16
physics (16) 16
receptors, estrogen - metabolism (16) 16
testing (16) 16
antimitotic agents (15) 15
antineoplastic agents - adverse effects (15) 15
antineoplastic combined chemotherapy protocols - administration & dosage (15) 15
biomarkers, tumor - metabolism (15) 15
drug administration schedule (15) 15
fluorouracil - administration & dosage (15) 15
medical prognosis (15) 15
medicine (15) 15
receptors, progesterone - metabolism (15) 15
survival rate (15) 15
cancer research (14) 14
chemotherapy, adjuvant (14) 14
disease progression (14) 14
everolimus (14) 14
gene expression regulation, neoplastic (14) 14
sirolimus - analogs & derivatives (14) 14
survival analysis (14) 14
taxoids - administration & dosage (14) 14
brain neoplasms - drug therapy (13) 13
development and progression (13) 13
estrogen (13) 13
immunohistochemistry (13) 13
postmenopausal women (13) 13
postmenopause (13) 13
antibodies, monoclonal, humanized (12) 12
antineoplastic agents - administration & dosage (12) 12
double-blind method (12) 12
follow-up studies (12) 12
oncology, experimental (12) 12
proteins (12) 12
retrospective studies (12) 12
studies (12) 12
toxicity (12) 12
antineoplastic agents - pharmacology (11) 11
biochemistry & molecular biology (11) 11
cell biology (11) 11
deoxycytidine - analogs & derivatives (11) 11
endocrine therapy (11) 11
epirubicin - administration & dosage (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 10/2015, Volume 16, Issue 13, pp. 1324 - 1334
Journal Article
Transplantation, ISSN 0041-1337, 12/2016, Volume 100, Issue 12, pp. 2569 - 2583
ABSTRACTSolid-organ transplant recipients are at increased risk of developing de novo malignancies compared with the general population, and malignancies... 
Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2015, Volume 372, Issue 8, pp. 724 - 734
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 06/2009, Volume 27, Issue 16, pp. 2630 - 2637
Journal Article
The lancet oncology, ISSN 1470-2045, 05/2013, Volume 14, Issue 6, pp. 461 - 471
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis | Index Medicus
Journal Article